• Home
  • >
  • Sequent Scientific Ltd Financials
https://storage.googleapis.com/assets.cdp.blinkx.in/Blinkx_Website/icons/sequent-scientific-ltd.png Logo

Sequent Scientific Ltd Financial Statement

Sequent Scientific Ltd Income Statement
Quarterly
Annual

*All values are in Rs. Cr

(Rs. CR)Mar 2024Dec 2023Sep 2023
Revenue49.7555.6558.99
Operating Expense42.5146.3656.82
Net Profit3.764.58-0.92
Net Profit Margin7.568.23-1.56
Earning Per Share0.150.18-0.04
EBIDTA6.98.244.14
Effective Tax RateTBA4.9569.12

(Rs. Cr)

Revenue

Operating Expense

Net Profit

Net Profit Margin

Earning Per Share

EBIDTA

Effective Tax Rate

Sequent Scientific Ltd Profit & Loss

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Total Revenue Annual1,420.911,412.821,361.62
Operating Expenses Annual1,408.951,303.421,149.55
Operating Profit Annual-46.45120.25211.61
Interest Annual35.5215.7724.38
Depreciation45.244.1440.78
Net Profit Annual-121.1640.9695.44
Tax Annual-15.688.1732.18

Particulars

Total Revenue Annual

Operating Expenses Annual

Operating Profit Annual

Interest Annual

Depreciation

Net Profit Annual

Tax Annual

Sequent Scientific Ltd Cash Flow

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Cash Flow at the Beginning57.553.7468.1
Cash Flow from Operations16.8130.6114.75
Cash Flow from Investing-64.96-94.19.65
Cash Flow from Financing32.2367.26-138.75
Cash Flow at the End41.5757.553.74

Particulars

Cash Flow at the Beginning

Cash Flow from Operations

Cash Flow from Investing

Cash Flow from Financing

Cash Flow at the End

Sequent Scientific Ltd Key Ratios

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
PBDIT Margin (%)1.148.5115.54
PBIT Margin (%)-2.784.8611.82
PBT Margin (%)-2.282.879.33
Net PROFIT Margin (%)-2.736.7412.1
Return On Networth / Equity (%)-9.046.3113.98
Return On Networth /Employed(%)-3.526.5714.62
Return On Assets (%)-3.338.6914.88
Total Debt / Equity(X)0.020.010.02
Asset Turnover Ratio (%)1.221.291.23

Particulars

PBDIT Margin (%)

PBIT Margin (%)

PBT Margin (%)

Net PROFIT Margin (%)

Return On Networth / Equity (%)

Return On Networth / Employed(%)

Return On Assets (%)

Total Debt / Equity(X)

Asset Turnover Ratio (%)

Sequent Scientific Ltd Balance Sheet

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Fixed Assets Annual609.21567.26537.67
Total Current Assets Annual789.89783.18713.59
Non Current Assets Annual739.24667.79678.97
Total Shareholders Funds Annual698.78692.1727.65
Total Assets Annual1,529.121,450.971,392.56

Particulars

Fixed Assets Annual

Total Current Assets Annual

Non Current Assets Annual

Total Shareholders Funds Annual

Total Assets Annual

Sequent Scientific Ltd Earning Calls
Mar 2024
EPS beaten by 0.00 %

Open Demat Account

50years
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O

Dividend Pages

PE Ratio

Get Your FAQs Right

As of May 20, 2024, Sequent Scientific Ltd has a market capitalization of 2,875.97 Cr. Value Research classifies it as a Mid-Cap company.

No, Sequent Scientific Ltd is not debt-free with a debt-to-equity ratio of 0.74.

In FY 2023, Sequent Scientific Ltd recorded a total revenue of approximately 1,369.73 Cr marking a significant milestone in the company's financial performance.

Sequent Scientific Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.1% and -0.0% annually, respectively..

Sequent Scientific Ltd's current PE ratio is -80.18.

Sequent Scientific Ltd's ROCE averaged 1.4% from the FY ending March 2022 to 2024, with a median of 0.9%. It peaked at 6.5% in March 2022, reflecting strong capital efficiency over the period..

Sequent Scientific Ltd's latest EBIT is Rs. -6.56 Cr, surpassing the average EBIT of Rs. -13.33 Cr over the 5 years..